Skip to main content

Table 2 Health outcomes assessed in the EU exposome projects

From: Unravelling the chemical exposome in cohort studies: routes explored and steps to become comprehensive

Health outcome

HELIX

HEALS

EXPOsOMICS

HBM4EU

Allergies/asthma

Yes

Yes

  

Neurodevelopment

Yes

Yes

 

Ongoing

Weight development

Yes

Yes

  

Obesity

Yes

Yes

  

Type 2 diabetes

Yes

   

Neurodegenerative diseases

Yes

   

Cancer

Yes

 

Yes

Yes

Acute coronary events and blood pressure

  

Yes

 
  1. Please refer to Additional file 1: Table S1 for a detailed overview regarding the characteristics of the used cohort studies including study design, sample size, age, time of enrolment, and gender ratio